Transdermal Drug Delivery Devices Market

DelveInsight’s ‘Transdermal Drug Delivery Devices -Market Insights, Competitive Landscape and Market Forecast - 2026’ report delivers an in-depth understanding of Transdermal Drug Delivery Devices and the historical and forecasted Transdermal Drug Delivery Devices market trends in the US, EU5 (Germany, Spain, Italy, France and United Kingdom) and Japan.


The Transdermal Drug Delivery Devices market report provides an overview of Transdermal Drug Delivery Devices , as well as its PEST Analysis. Additionally, the report provides insight on the Transdermal Drug Delivery Devices market share of the individual Transdermal Drug Delivery Devices devices, current and forecasted Transdermal Drug Delivery Devices market size from 2018 to 2026 segmented by seven major markets. The report also covers the market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses underlying potential of the market.

Transdermal Drug Delivery Devices Overview

Transdermal drug delivery systems are an alternative to the intravascular, subcutaneous, and transmucosal oral routes through which the drugs are delivered for therapeutic use through the skin. Market growth is expected to be driven by an increase in the geriatric population and an upsurge in the number of patients with chronic disorders.


Study Period: 2018–2026

Geography Covered

  • The US
  • EU5 (Germany, France, Italy, Spain and the United Kingdom)
  • Japan

List of Companies:

  • Hisamitsu Pharmaceutical (Japan)
  • Mylan (US)
  • UCB (Belgium)
  • Novartis (Switzerland)
  • GlaxoSmithKline (UK)
  • Boehringer Ingelheim (Germany)
  • Johnson & Johnson (US)
  • Endo International (Ireland)
  • Purdue Pharma (US).

Transdermal Drug Delivery Devices - Competitive Analysis

This segment of the report provides a brief competitive analysis of Transdermal Drug Delivery Devices , to help understand the competition in the market. It gives a comparative understanding of the products based on types of delivery system.

Transdermal Drug Delivery Devices : Market Segmentation

By Applications

  • Pain Management
  • Hormonal Applications
  • Central Nervous System Disorders
  • Cardiovascular Diseases
  • Others


By Type of Delivery System

  • Passive
  • Active
  • Others


By Product

  • Transdermal Patches
  • Transdermal Semisolids

Transdermal Drug Delivery Devices : Market Dynamics

Market Drivers

  • Increase in the adoption of third-generation transdermal drug delivery systems
  • Increase in the prevalence of chronic diseases
  • Technological advancements in transdermal drug delivery systems


Market Barriers

  • Disadvantages of these delivery systems, such as irritation at the site of application and edema

Transdermal Drug Delivery Devices : Market Analysis

This segment illustrates the market of Transdermal Drug Delivery Devices across 7MM and how the market is expected to rise in the study period (2018 to 2026), at a significant CAGR.

KOL- Views

To keep up with the market trends, we take KOLs and SME’s opinion working in Transdermal Drug Delivery Devices domain through primary research to fill the data gaps and validate our secondary research. Their opinion helps to understand and validate current and emerging therapies treatment patterns or Transdermal Drug Delivery Devices market trend. This will support the clients in making informed business decisions by identifying the overall scenario of the market and the unmet needs.

Scope of the Report

  • The report covers the descriptive overview of Transdermal Drug Delivery Devices , explaining its applications, advantages, and limitations, etc.
  • Additionally, an all-inclusive account of the currently available Transdermal Drug Delivery Devices is provided, which will have an impact on the future market of Transdermal Drug Delivery Devices .
  • A detailed review of Transdermal Drug Delivery Devices market; historical and forecasted market size is included in the report, covering devices outreach in the 7MM.
  • The report provides an edge while developing business strategies, by understanding trends shaping and driving the Transdermal Drug Delivery Devices market.

Report Highlights

  • The report covers descriptive overview of the Transdermal Drug Delivery Devices , explaining its applications, working mechanism, etc.
  • The report is a comprehensive account of marketed devices present in the Transdermal Drug Delivery Devices market.
  • The report also reviews the detailed global historical and forecasted Transdermal Drug Delivery Devices market including assessing the outreach in 7 MM.
  • The report helps in developing business strategies by understanding trends shaping and driving the Transdermal Drug Delivery Devices market.

Transdermal Drug Delivery Devices Report Key Strengths

  • 6 Years Forecast
  • 7MM Coverage
  • Competitive Landscape
  • PEST Analysis
  • Market Size

Transdermal Drug Delivery Devices Report Assessment

  • Marketed Product profiles
  • Key Products and Key Players
  • Market Drivers and Barriers
  • Market Forecast
  • KOL’S views

Key Questions

Market Insights:

  • What was the Transdermal Drug Delivery Devices market share (%) distribution in 2018 and how it will look like in 2026?
  • What will be the Transdermal Drug Delivery Devices total market Size as well as market Size by devices across the 7MM during the forecast period (2018–2026)?
  • What are the key findings pertaining to the market across 7MM and which country will have the largest Transdermal Drug Delivery Devices market Size during the forecast period (2018–2026)?
  • At what CAGR, the Transdermal Drug Delivery Devices market is expected to grow in 7MM during the forecast period (2018–2026)?
  • What will be the Transdermal Drug Delivery Devices market outlook across the 7MM during the forecast period (2018–2026)?
  • What will be the Transdermal Drug Delivery Devices market growth till 2026 and what will be the resultant market size in the year 2026?
  • How will the market drivers, barriers and future opportunities affect the market dynamics and a subsequent analysis of the associated trends?


Competitive Landscape:

  • What are the current devices available in the Transdermal Drug Delivery Devices market?
  • What is the Transdermal Drug Delivery Devices available in the market, their product description, regulatory milestones, product development activities, research and development activities etc.?
  • How many key players are developing Transdermal Drug Delivery Devices?
  • What are the key collaborations (Industry–Industry), Mergers and acquisitions, licensing activities related to the Transdermal Drug Delivery Devices?
  • What are the key designations that have been granted for the current Transdermal Drug Delivery Devices?
  • What are the global historical and forecasted market of Transdermal Drug Delivery Devices?

Frequently Asked Questions:

What are Transdermal Drug Delivery Devices?

Transdermal drug delivery systems are an alternative to the intravascular, subcutaneous, and transmucosal oral routes through which the drugs are delivered for therapeutic use through the skin.


How is the Transdermal Drug Delivery Devices Market Segmented?

The Transdermal Drug Delivery Devices is segmented on the basis of Product Type, Channel Type and End User.


Who are the leading companies in Transdermal Drug Delivery Devices Market Landscape?

The leading companies that are working in the Transdermal Drug Delivery Devices Market are Hisamitsu Pharmaceutical, Mylan, UCB, Novartis and Others


What are the Transdermal Drug Delivery Devices Market Drivers?

Some of the market drivers are increase in the adoption of third-generation transdermal drug delivery systems, increase in the prevalence of chronic diseases and technological advancements in transdermal drug delivery systems.


What are the Transdermal Drug Delivery Devices Market Barriers?

Some of the market barriers are Disadvantages of these delivery systems, such as irritation at the site of application and edema.


What are the key strengths of the Transdermal Drug Delivery Devices Market Report?

Key strengths of Transdermal Drug Delivery Devices Market Report are 6 Years Forecast, 7MM Coverage, Competitive Landscape, PEST Analysis, Market Size, Market Drivers and Market Barriers.


What is the Impact of Covid-19 on the Transdermal Drug Delivery Devices Market?

The Transdermal Drug Delivery Devices Market has observed a positive shift in market revenues due to the Covid 19 in 2020. The report includes the factors that are contributing to this significant increase in detail.

1. Key Insights

2. Executive Summary of Transdermal Drug Delivery Devices

3. Transdermal Drug Delivery Devices: Background and Overview

3.1. Introduction

4. Transdermal Drug Delivery Devices: Regulatory Scenario

5. Transdermal Drug Delivery Devices: Reimbursement Scenario

6. Company Profiles

6.1. Hisamitsu Pharmaceutical

6.1.1. Company Overview

6.1.2. Product Portfolio

6.1.2.1. Product description

6.1.2.2. Regulatory Milestones

6.1.2.3. Research and Development

6.1.2.4. Product Development Activities

6.2. Mylan

6.2.1. Company Overview

6.2.2. Product Portfolio

6.2.2.1. Product description

6.2.2.2. Regulatory Milestones

6.2.2.3. Research and Development

6.2.2.4. Product Development Activities

Products detail in the report…

7. Transdermal Drug Delivery Devices: Competitive Analysis

8. KOL Views

9. Transdermal Drug Delivery Devices: Market Analysis in 7MM

9.1. Transdermal Drug Delivery Devices: Market Analysis in 7MM by Application (2018–2026)

9.2. Transdermal Drug Delivery Devices: Market Analysis in 7MM by Type of Delivery System (2018–2026)

9.3. Transdermal Drug Delivery Devices: Market Analysis n 7MM by Product (2018–2026)

10. Country-Wise Market size of Transdermal Drug Delivery Devices in 7MM (2018–2026)

10.1. Market size of Transdermal Drug Delivery Devices in the United States

10.1.1. Transdermal Drug Delivery Devices: Market Analysis in the United State by Application (2018–2026)

10.1.2. Transdermal Drug Delivery Devices: Market Analysis in the United State by Type of Delivery System (2018–2026)

10.1.3. Transdermal Drug Delivery Devices: Market Analysis in the United State by Product (2018–2026)

10.2. Market size of Transdermal Drug Delivery Devices in France

10.2.1. Transdermal Drug Delivery Devices: Market Analysis in France by Application (2018–2026)

10.2.2. Transdermal Drug Delivery Devices: Market Analysis in France by Type of Delivery System (2018–2026)

10.2.3. Transdermal Drug Delivery Devices: Market Analysis in France by Product (2018–2026)

10.3. Market size of Transdermal Drug Delivery Devices in Italy

10.3.1. Transdermal Drug Delivery Devices: Market Analysis in Italy by Application (2018–2026)

10.3.2. Transdermal Drug Delivery Devices: Market Analysis in Italy by Type of Delivery System (2018–2026)

10.3.3. Transdermal Drug Delivery Devices: Market Analysis in Italy by Product (2018–2026)

10.4. Market size of Transdermal Drug Delivery Devices in the UK

10.4.1. Transdermal Drug Delivery Devices: Market Analysis in the UK by Application (2018–2026)

10.4.2. Transdermal Drug Delivery Devices: Market Analysis in the UK by Type of Delivery System (2018–2026)

10.4.3. Transdermal Drug Delivery Devices: Market Analysis in the UK by Product (2018–2026)

10.5. Market size of Transdermal Drug Delivery Devices in Spain

10.5.1. Transdermal Drug Delivery Devices: Market Analysis in Spain by Application (2018–2026)

10.5.2. Transdermal Drug Delivery Devices: Market Analysis in Spain by Type of Delivery System (2018–2026)

10.5.3. Transdermal Drug Delivery Devices: Market Analysis in Spain by Product (2018–2026)

10.6. Market size of Transdermal Drug Delivery Devices in Germany

10.6.1. Transdermal Drug Delivery Devices: Market Analysis in Germany by Application (2018–2026)

10.6.2. Transdermal Drug Delivery Devices: Market Analysis in Germany by Type of Delivery System (2018–2026)

10.6.3. Transdermal Drug Delivery Devices: Market Analysis in Germany by Product (2018–2026)

10.7. Market size of Transdermal Drug Delivery Devices in Japan

10.7.1. Transdermal Drug Delivery Devices: Market Analysis in Japan by Application (2018–2026)

10.7.2. Transdermal Drug Delivery Devices: Market Analysis in Japan by Type of Delivery System (2018–2026)

10.7.3. Transdermal Drug Delivery Devices: Market Analysis in Japan by Product (2018–2026)

11. Market Dynamic

11.1. Market Drivers

11.2. Market Barriers

12. PEST Analysis

13. Conclusion and Future Perspective

14. Appendix

14.1. Bibliography

14.2. Report Methodology

15. DelveInsight Capabilities

16. Disclaimer

17. About DelveInsight

List of Table

Table 1: Competitive Analysis

Table 2: Transdermal Drug Delivery Devices Market Analysis in the 7MM (2018–2026)

Table 3: Transdermal Drug Delivery Devices Market Analysis in the 7MM by Application (2018–2026)

Table 4: Transdermal Drug Delivery Devices Market Analysis in the 7MM by Type of delivery system (2018–2026)

Table 5: Transdermal Drug Delivery Devices Market Analysis in the 7MM by Product (2018–2026)

Table 6: Transdermal Drug Delivery Devices in the US Market Analysis (2018–2026)

Table 7: Transdermal Drug Delivery Devices Market Analysis in the US by Application (2018-2026)

Table 8: Transdermal Drug Delivery Devices Market Analysis in the US by Type of delivery system (2018-2026)

Table 9: Transdermal Drug Delivery Devices Market Analysis in the US by Product (2018-2026)

Table 10: Transdermal Drug Delivery Devices Market Analysis in Germany (2018–2026)

Table 11: Transdermal Drug Delivery Devices Market Analysis in Germany by Application (2018-2026)

Table 12: Transdermal Drug Delivery Devices Market Analysis in Germany by Type of delivery system (2018-2026)

Table 13: Transdermal Drug Delivery Devices Market Analysis in Germany by Product (2018-2026)

Table 14: Transdermal Drug Delivery Devices Market Analysis in France (2018–2026)

Table 15: Transdermal Drug Delivery Devices Market Analysis in France by Application (2018-2026)

Table 16: Transdermal Drug Delivery Devices Market Analysis in France by Type of delivery system (2018–2026)

Table 17: Transdermal Drug Delivery Devices Market Analysis in France by Product (2018–2026)

Table 18: Transdermal Drug Delivery Devices Market Analysis in Spain (2018–2026)       

Table 19: Transdermal Drug Delivery Devices Market Analysis in Spain by Application (2018–2026)

Table 20: Transdermal Drug Delivery Devices Market Analysis in Spain by Type of delivery system (2018–2026)

Table 21: Transdermal Drug Delivery Devices Market Analysis in Spain by Product (2018–2026)

Table 22: Transdermal Drug Delivery Devices Market Analysis in Italy (2018–2026)

Table 23: Transdermal Drug Delivery Devices Market Analysis in Italy by Application (2018–2026)

Table 24: Transdermal Drug Delivery Devices Market Analysis in Italy by Type of delivery system (2018–2026)

Table 25: Transdermal Drug Delivery Devices Market Analysis in Italy by Product (2018–2026)

Table 26: Transdermal Drug Delivery Devices Market Analysis in the United Kingdom (2018–2026)

Table 27: Transdermal Drug Delivery Devices Market Analysis in the United Kingdom by Application (2018–2026)

Table 28: Transdermal Drug Delivery Devices Market Analysis in the United Kingdom by Type of delivery system (2018–2026)

Table 29: Transdermal Drug Delivery Devices Market Analysis in the United Kingdom by Product (2018–2026)

Table 30: Transdermal Drug Delivery Devices Market Analysis in Japan (2018–2026)

Table 31: Transdermal Drug Delivery Devices Market Analysis in Japan by Application (2018–2026)

Table 32: Transdermal Drug Delivery Devices Market Analysis in Japan by Type of delivery system (2018–2026)

Table 33: Transdermal Drug Delivery Devices Market Analysis in Japan by Product (2018–2026)

List of Figures

Figure 1: Product description of Transdermal Drug Delivery Devices

Figure 2: Transdermal Drug Delivery Devices Market Analysis in the 7MM (2018–2026)

Figure 3: Transdermal Drug Delivery Devices Market Analysis in the 7MM by Application (2018–2026)

Figure 4: Transdermal Drug Delivery Devices Market Analysis in the 7MM by Type of delivery system (2018–2026)

Figure 5: Transdermal Drug Delivery Devices Market Analysis in the 7MM by Product (2018–2026)

Figure 6: Transdermal Drug Delivery Devices in the US (2018–2026)

Figure 7: Transdermal Drug Delivery Devices Market Analysis in the US by Application (2018-2026)

Figure 8: Transdermal Drug Delivery Devices Market Analysis in the US by Type of delivery system (2018-2026)

Figure 9: Transdermal Drug Delivery Devices Market Analysis in the US by Product (2018-2026)

Figure 10: Transdermal Drug Delivery Devices Market Analysis in Germany (2018–2026)

Figure 11: Transdermal Drug Delivery Devices Market Analysis in Germany by Application (2018-2026)

Figure 12: Transdermal Drug Delivery Devices Market Analysis in Germany by Type of delivery system (2018-2026)

Figure 13: Transdermal Drug Delivery Devices Market Analysis in Germany by Product (2018-2026)

Figure 14: Transdermal Drug Delivery Devices Market Analysis in France (2018–2026)

Figure 15: Transdermal Drug Delivery Devices Market Analysis in France by Application (2018–2026)

Figure 16: Transdermal Drug Delivery Devices Market Analysis in France by Type of delivery system (2018–2026)

Figure 17: Transdermal Drug Delivery Devices Market Analysis in France by Product (2018–2026)

Figure 18: Transdermal Drug Delivery Devices Market Analysis in Spain (2018–2026)

Figure 19: Transdermal Drug Delivery Devices Market Analysis in Spain by Application (2018–2026)

Figure 20: Transdermal Drug Delivery Devices Market Analysis in Spain by Type of delivery system (2018–2026)

Figure 21: Transdermal Drug Delivery Devices Market Analysis in Spain by Product (2018–2026)

Figure 22: Transdermal Drug Delivery Devices Market Analysis in Italy (2018–2026)

Figure 23: Transdermal Drug Delivery Devices Market Analysis in Italy by Application (2018–2026)

Figure 24: Transdermal Drug Delivery Devices Market Analysis in Italy by Type of delivery system (2018–2026)

Figure 25: Transdermal Drug Delivery Devices Market Analysis in Italy by Product (2018–2026)

Figure 26: Transdermal Drug Delivery Devices Market Analysis in United Kingdom (2018–2026)

Figure 27: Transdermal Drug Delivery Devices Market Analysis in the United Kingdom by Application (2018–2026)

Figure 28: Transdermal Drug Delivery Devices Market Analysis in the United Kingdom by Type of delivery system (2018–2026)

Figure 29: Transdermal Drug Delivery Devices Market Analysis in the United Kingdom by Product (2018–2026)

Figure 30: Transdermal Drug Delivery Devices Market Analysis in Japan (2018–2026)       

Figure 31: Transdermal Drug Delivery Devices Market Analysis in Japan by Application (2018–2026)

Figure 32: Transdermal Drug Delivery Devices Market Analysis in Japan by Type of delivery system (2018–2026)

Figure 33: Transdermal Drug Delivery Devices Market Analysis in Japan by Product (2018–2026)

Figure 34: Market Drivers

Figure 35: Market Barriers

Hisamitsu Pharmaceutical (Japan)

Mylan (US)

UCB (Belgium)

Novartis (Switzerland)

GlaxoSmithKline (UK)

Boehringer Ingelheim (Germany)

Johnson & Johnson (US)

Endo International (Ireland)

Purdue Pharma (US).

  • Tags:
  • Transdermal Drug Delivery Devices
  • Transdermal Drug Delivery Devices...
  • Transdermal Drug Delivery Devices...
  • Transdermal Drug Delivery Devices...
  • Transdermal Drug Delivery Devices...
  • Transdermal Drug Delivery Devices...
  • Transdermal Drug Delivery Devices...
  • Transdermal Drug Delivery Devices...
  • Transdermal Drug Delivery Devices...
  • Transdermal Drug Delivery Devices...

Forward to Friend

Need A Quote